FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / formal-protest-draft-v1.docx
formal-protest-draft-v1.docx · 1018-00009

Parties

Harkness LLP
Penterra Pharmaceuticals Corp
United States Corporation Inc
Intent Penterra Pharmaceuticals Corp
Corporate Overview Penterra Pharmaceuticals Corp
Penterra Manufacturing Ireland Ltd
Ireland Inc
Manufacturer Penterra Manufacturing Ireland Ltd

Dates

December 5, 2023
December 31, 2017
December 31, 2018
December 31, 2019
December 31, 2020
October 12, 2023
November 8, 2023
December 8, 2023
December 22, 2023
June 8, 2022

Amounts

$380,400,000
$15,977,000
$6.82
$1.47
€47.2
€2.14
€1.06
$3.12
$1.34
$1.87

Obligations

" The touchstone of IRC § 482 is the arm's-length standard: controlled transactions must produce results consistent with those that would have been realized if uncontrolled taxpayers had engaged in the same transaction under the same circumstances
The regulations prescribe specific requirements for a valid QCSA, including: (a) Controlled participant eligibility: Each participant must be a controlled taxpayer that reasonably anticipates benefits from the exploitation of the intangible property
(b) Intangible development activities: The CSA must relate to the development of specifically identified intangible property through research and development activities
(d) Platform contribution transactions ("PCTs"): When a participant contributes pre-existing resources, capabilities, or rights to the CSA, a PCT payment is required to compensate the contributor
The PCT payment must reflect the arm's-length value of the pre-existing contributions
The court noted that the CUT method can be reliable when properly applied, but that comparability deficiencies must be addressed through appropriate adjustments